Scancell Holdings PLC (SCLP)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
9.50p
Buy
10.50p
0.00p (+0.00%)
Prices updated at 09 May 2025, 16:19 BST
| Prices minimum 15 mins delay
Prices in GBX
Scancell Holdings PLC is a biopharmaceutical company focused on the cancer therapeutics market. The company's principal activity consists of the discovery and development of monoclonal antibodies and vaccines for the treatment of cancer.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
10.50p - 9.50p | |
19.75p - 7.26p | |
- | |
103.68m | |
- | |
30,000 | |
252,103 | |
- | |
892,386.26 | |
1.42 | |
928.98m | |
GB00B63D3314 | |
-0.02 | |
- |
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.